Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07382557 · ClinicalTrials.gov registry record · NA

Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System

A NA study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
1
Study location

NCT07382557: Recruiting NA study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.

NCT07382557 is a NA study of Lung Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 360 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07382557, a NA study of Lung Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

The goal of the study is to adapt and test a participant decision aid about lung cancer screening for use with patients in theHarris Health System (HHS).

Conditions Studied

Interventions

  • OTHER Surveys
  • OTHER Focus groups
  • OTHER Cognitive Interviews
  • BEHAVIORAL Lung cancer screening decision aid video
  • BEHAVIORAL Colon cancer screening video

Study Locations (1)

Texas

  • The University of Texas M. D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2022-09-29
Est. Completion 2027-02-02
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT07382557

The ClinicalTrials.gov registry entry for NCT07382557 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (61% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which Surveys is the first listed.

NCT07382557 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07382557 about?

NCT07382557 is a clinical study titled "Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System". The goal of the study is to adapt and test a participant decision aid about lung cancer screening for use with patients in theHarris Health System (HHS).

What is the current status of trial NCT07382557?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2022-09-29. Estimated completion is 2027-02-02.

What conditions does trial NCT07382557 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT07382557?

The interventions under investigation include: Surveys (OTHER), Focus groups (OTHER), Cognitive Interviews (OTHER), Lung cancer screening decision aid video (BEHAVIORAL), Colon cancer screening video (BEHAVIORAL).

Who is sponsoring clinical trial NCT07382557?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07382557 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.